Regarding the MITO subgroups, significantly elevated FGF21 and GDF15 levels were observed in subgroups with primary muscular phenotype (CPEO, CPEO-plus), while not significantly altered in all other subgroups (Fig. 3a, b). This evidence concerns the gene GDF15 and External ophthalmoplegia.